Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs and Physical Therapy in MS
NCT03326505Phase 2Completed
- Sponsor
- University of Jordan
- Start
- Sep 2017
- Primary completion
- Jan 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in multiple sclerosis (MS), sponsored by University of Jordan. Started Sep 2017; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03326505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03326505.